These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 23806224

  • 1. Efficient boosting of the antiviral T cell response in B cell-depleted patients with autoimmune rheumatic diseases following influenza vaccination.
    Muller RB, Maier R, Hoschler K, Zambon M, Ludewig B, Herrmann M, Schulze-Koops H, von Kempis J.
    Clin Exp Rheumatol; 2013; 31(5):723-30. PubMed ID: 23806224
    [Abstract] [Full Text] [Related]

  • 2. Rituximab-treated patients have a poor response to influenza vaccination.
    Eisenberg RA, Jawad AF, Boyer J, Maurer K, McDonald K, Prak ET, Sullivan KE.
    J Clin Immunol; 2013 Feb; 33(2):388-96. PubMed ID: 23064976
    [Abstract] [Full Text] [Related]

  • 3. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP, Phoon MC, Koh GC, Chen MI, Lee VJ, Wu Y, Xie ML, Cheong A, Leo YS, Chow VT.
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and safety of two doses of a non-adjuvanted influenza A H1N1/2009 vaccine in young autoimmune rheumatic diseases patients.
    Aikawa NE, Trudes G, Campos LM, Pereira RM, Moraes JC, Ribeiro AC, Miraglia J, Timenetsky Mdo C, Bonfa E, Silva C.
    Lupus; 2013 Nov; 22(13):1394-8. PubMed ID: 24076765
    [Abstract] [Full Text] [Related]

  • 5. The impact of immunosenescence on humoral immune response variation after influenza A/H1N1 vaccination in older subjects.
    Haralambieva IH, Painter SD, Kennedy RB, Ovsyannikova IG, Lambert ND, Goergen KM, Oberg AL, Poland GA.
    PLoS One; 2015 Nov; 10(3):e0122282. PubMed ID: 25816015
    [Abstract] [Full Text] [Related]

  • 6. Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.
    Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.
    Rheumatology (Oxford); 2012 Apr; 51(4):695-700. PubMed ID: 22171015
    [Abstract] [Full Text] [Related]

  • 7. Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
    Issa NC, Marty FM, Gagne LS, Koo S, Verrill KA, Alyea EP, Cutler CS, Koreth J, Armand P, Ho VT, Antin JH, Soiffer RJ, Baden LR.
    Biol Blood Marrow Transplant; 2011 Mar; 17(3):434-8. PubMed ID: 20950701
    [Abstract] [Full Text] [Related]

  • 8. Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease.
    Perdan-Pirkmajer K, Thallinger GG, Snoj N, Čučnik S, Žigon P, Kveder T, Logar D, Praprotnik S, Tomšič M, Sodin-Semrl S, Ambrožič A.
    Lupus; 2012 Feb; 21(2):175-83. PubMed ID: 22235050
    [Abstract] [Full Text] [Related]

  • 9. The immunogenicity of seasonal and pandemic influenza vaccination in autoimmune inflammatory rheumatic patients-a 6-month follow-up prospective study.
    Lakota K, Perdan-Pirkmajer K, Sodin-Šemrl S, Čučnik S, Šubelj V, Prosenc K, Mrak Poljšak K, Tomšič M, Ambrožič A, Praprotnik S.
    Clin Rheumatol; 2019 May; 38(5):1277-1292. PubMed ID: 30761436
    [Abstract] [Full Text] [Related]

  • 10. The response to vaccination against influenza A(H1N1) 2009, seasonal influenza and Streptococcus pneumoniae in adult outpatients with ongoing treatment for cancer with and without rituximab.
    Berglund A, Willén L, Grödeberg L, Skattum L, Hagberg H, Pauksens K.
    Acta Oncol; 2014 Sep; 53(9):1212-20. PubMed ID: 24865118
    [Abstract] [Full Text] [Related]

  • 11. Cellular and humoral cross-immunity against two H3N2v influenza strains in presumably unexposed healthy and HIV-infected subjects.
    Agrati C, Castilletti C, Cimini E, Lapa D, Quartu S, Caglioti C, Lanini S, Cattoli G, Martini F, Ippolito G, Capobianchi MR.
    PLoS One; 2014 Sep; 9(8):e105651. PubMed ID: 25162670
    [Abstract] [Full Text] [Related]

  • 12. The cellular immune response to influenza vaccination is preserved in rheumatoid arthritis patients treated with rituximab.
    Arad U, Tzadok S, Amir S, Mandelboim M, Mendelson E, Wigler I, Sarbagil-Maman H, Paran D, Caspi D, Elkayam O.
    Vaccine; 2011 Feb 11; 29(8):1643-8. PubMed ID: 21211590
    [Abstract] [Full Text] [Related]

  • 13. Vaccination against influenza in patients with systemic sclerosis.
    Litinsky I, Balbir A, Zisman D, Mandelboim M, Mendelson E, Feld J, Braun Y, Anouk M, Kaufman I, Paran D, Caspi D, Elkayam O.
    Clin Exp Rheumatol; 2012 Feb 11; 30(2 Suppl 71):S7-11. PubMed ID: 22409886
    [Abstract] [Full Text] [Related]

  • 14. Low expression of activation marker CD69 and chemokine receptors CCR5 and CXCR3 on memory T cells after 2009 H1N1 influenza A antigen stimulation in vitro following H1N1 vaccination of HIV-infected individuals.
    Chawansuntati K, Chotirosniramit N, Sugandhavesa P, Aurpibul L, Thetket S, Kosashunhanan N, Supindham T, Kaewthip O, Sroysuwan P, Sirisanthana T, Suparatpinyo K, Wipasa J.
    Hum Vaccin Immunother; 2015 Feb 11; 11(9):2253-65. PubMed ID: 26091502
    [Abstract] [Full Text] [Related]

  • 15. CD4+ T-cell immunity after pandemic influenza vaccination cross-reacts with seasonal antigens and functionally differs from active influenza infection.
    Schmidt T, Dirks J, Enders M, Gärtner BC, Uhlmann-Schiffler H, Sester U, Sester M.
    Eur J Immunol; 2012 Jul 11; 42(7):1755-66. PubMed ID: 22585549
    [Abstract] [Full Text] [Related]

  • 16. Cellular and humoral influenza-specific immune response upon vaccination in patients with common variable immunodeficiency and unclassified antibody deficiency.
    Hanitsch LG, Löbel M, Mieves JF, Bauer S, Babel N, Schweiger B, Wittke K, Grabowski P, Volk HD, Scheibenbogen C.
    Vaccine; 2016 May 05; 34(21):2417-2423. PubMed ID: 27055021
    [Abstract] [Full Text] [Related]

  • 17. Vaccination and auto-immune rheumatic diseases: lessons learnt from the 2009 H1N1 influenza virus vaccination campaign.
    Touma Z, Gladman DD, Urowitz MB.
    Curr Opin Rheumatol; 2013 Mar 05; 25(2):164-70. PubMed ID: 23370371
    [Abstract] [Full Text] [Related]

  • 18. Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies.
    Héquet D, Pascual M, Lartey S, Pathirana RD, Bredholt G, Hoschler K, Hullin R, Meylan P, Cox RJ, Manuel O.
    Vaccine; 2016 Jun 30; 34(31):3576-83. PubMed ID: 27219339
    [Abstract] [Full Text] [Related]

  • 19. H1N1 vaccination in pediatric renal transplant patients.
    Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ.
    Transplant Proc; 2011 May 30; 43(4):1244-6. PubMed ID: 21620100
    [Abstract] [Full Text] [Related]

  • 20. Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies.
    Mariotti J, Spina F, Carniti C, Anselmi G, Lucini D, Vendramin A, Pregliasco F, Corradini P.
    Eur J Haematol; 2012 Aug 30; 89(2):111-9. PubMed ID: 22540245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.